A critical advance in cancer investigation is emerging with the use of mini-antibodies to reactivate mutated p53. This vital malignant suppressor protein is frequently disabled in various kinds of tumors, causing https://thekiwisocial.com/story7563033/vhh-fragments-revive-p53-new-promising-hope-for-cancer-treatment